• 2016
  Polyakov P, Breban R, Bayesian Monitoring of Emerging Infectious Diseases, PLoS ONE 2016;11(4):e0152629.
• 2015
  Supervie V, Viard JP, Costagliola D, Breban R, Risk of HIV transmission under combined antiretroviral therapy: toward risk zero?, J. Acquir. Immune Defic. Syndr. 2015 Mar;68(3):e41-2.
• 2014
  Breban R, Fontanet A, Feasible HCV targets in Egypt – authors’ reply, Lancet Glob Health 2014 Dec;2(12):e688.
• 2014
  Breban R, Arafa N, Leroy S, Mostafa A, Bakr I, Tondeur L, Abdel-Hamid M, Doss W, Esmat G, Mohamed MK, Fontanet A, Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study, Lancet Glob Health 2014 Sep;2(9):e541-e549.
• 2014
  Supervie V, Viard JP, Costagliola D, Breban R, Heterosexual risk of HIV transmission per sexual act under combined antiretroviral therapy: systematic review and bayesian modeling, Clin. Infect. Dis. 2014 Jul;59(1):115-22.
• 2013
  Breban R, Riou J, Fontanet A, Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk, Lancet 2013 Aug;382(9893):694-9.
• 2012
  Breban R, Role of environmental persistence in pathogen transmission: a mathematical modeling approach, J Math Biol 2013 Feb;66(3):535-46.
• 2012
  Breban R, Bisiaux A, Biot C, Rentsch C, Bousso P, Albert ML, Mathematical model of tumor immunotherapy for bladder carcinoma identifies the limitations of the innate immune response, Oncoimmunology 2012 Jan;1(1):9-17.
• 2011
  Breban R, Health newscasts for increasing influenza vaccination coverage: an inductive reasoning game approach, PLoS ONE 2011;6(12):e28300.